NCT03901716View on ClinicalTrials.gov

Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 15, 2019

Study Completion Date

March 26, 2019

Conditions
SufentanilRemifentanilFentanylBronchoscopyNarcotrendConscious Sedation
Interventions
DRUG

Sufentanil

Patients in Group S received sufentanil 0.1 mcg/kg.

DRUG

Fentanyl

Patients in Group F received fentanyl 1 mcg/kg.

DRUG

Remifentanil

Patients in Group R received remifentanil target-controlled infusion with effect-site target concentration of 1ng/ml.

DRUG

Midazolam

Patients in all groups received midazolam to achieve moderate levels of sedation as assessed by the Narcotrend (NT; between B1 and C2).

Trial Locations (1)

510000

the First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT03901716 - Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation | Biotech Hunter | Biotech Hunter